Ryan J. Watts
President and CEO, Director · Denali Therapeutics Inc.
- 2024
- Aug 14, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ryan J. Watts files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nancy Thornberry - $262K in DNLI purchases and sales in the last 12 months
- Alexander O. Schuth - $137K in DNLI purchases and sales in the last 12 months
- Peter Scott Chin - $37K in DNLI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ryan J. Watts?
Ryan J. Watts is a corporate insider, tracked as President and CEO, Director of Denali Therapeutics Inc. (DNLI). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ryan J. Watts submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ryan J. Watts been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($8.54M) across all tracked filings.
